Cargando…
The Developing Story of Predictive Biomarkers in Colorectal Cancer
Colorectal cancer (CRC) is the third most common malignancy worldwide. Surgery remains the most important treatment for non-metastatic CRC, and the administration of adjuvant chemotherapy depends mainly on the disease stage, which is still the strongest prognostic factor. A refined understanding of...
Autores principales: | Boussios, Stergios, Ozturk, Mehmet Akif, Moschetta, Michele, Karathanasi, Afroditi, Zakynthinakis-Kyriakou, Nikolaos, Katsanos, Konstantinos H., Christodoulou, Dimitrios K., Pavlidis, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463186/ https://www.ncbi.nlm.nih.gov/pubmed/30736475 http://dx.doi.org/10.3390/jpm9010012 |
Ejemplares similares
-
PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”
por: Boussios, Stergios, et al.
Publicado: (2019) -
Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives
por: Boussios, Stergios, et al.
Publicado: (2018) -
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
por: Boussios, Stergios, et al.
Publicado: (2019) -
Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?
por: Boussios, Stergios, et al.
Publicado: (2020) -
Cancer-Associated Thrombosis: A New Light on an Old Story
por: Shah, Sidrah, et al.
Publicado: (2021)